I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InDex Pharmaceuticals Holding AB
Total Current Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Current Liabilities
kr31.6m
CAGR 3-Years
31%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Current Liabilities
kr429.8m
CAGR 3-Years
52%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Current Liabilities
kr428.8m
CAGR 3-Years
27%
CAGR 5-Years
29%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Current Liabilities
kr357.1m
CAGR 3-Years
61%
CAGR 5-Years
77%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Total Current Liabilities
kr36.7m
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Current Liabilities
kr20.5m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Total Current Liabilities?
Total Current Liabilities
31.6m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Total Current Liabilities amounts to 31.6m SEK.

What is InDex Pharmaceuticals Holding AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
7%

Over the last year, the Total Current Liabilities growth was -26%. The average annual Total Current Liabilities growth rates for InDex Pharmaceuticals Holding AB have been 31% over the past three years , 7% over the past five years .

Back to Top